Literature DB >> 10731151

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.

S Faure1, L Meyer, D Costagliola, C Vaneensberghe, E Genin, B Autran, J F Delfraissy, D H McDermott, P M Murphy, P Debré, I Théodorou, C Combadière.   

Abstract

Human immunodeficiency virus (HIV) enters cells in vitro via CD4 and a coreceptor. Which of 15 known coreceptors are important in vivo is poorly defined but may be inferred from disease-modifying mutations, as for CCR5. Here two single nucleotide polymorphisms are described in Caucasians in CX3CR1, an HIV coreceptor and leukocyte chemotactic/adhesion receptor for the chemokine fractalkine. HIV-infected patients homozygous for CX3CR1-I249 M280, a variant haplotype affecting two amino acids (isoleucine-249 and methionine-280), progressed to AIDS more rapidly than those with other haplotypes. Functional CX3CR1 analysis showed that fractalkine binding is reduced among patients homozygous for this particular haplotype. Thus, CX3CR1-I249 M280 is a recessive genetic risk factor in HIV/AIDS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731151     DOI: 10.1126/science.287.5461.2274

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  81 in total

Review 1.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

2.  Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

Authors:  P Fraticelli; M Sironi; G Bianchi; D D'Ambrosio; C Albanesi; A Stoppacciaro; M Chieppa; P Allavena; L Ruco; G Girolomoni; F Sinigaglia; A Vecchi; A Mantovani
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  The fractalkine receptor CX3CR1 is a key mediator of atherogenesis.

Authors:  Myron I Cybulsky; Robert A Hegele
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 4.  Host genetic factors in susceptibility to HIV-1 infection and progression to AIDS.

Authors:  Koushik Chatterjee
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

5.  Differential calcium signaling in dairy cows with specific CXCR1 genotypes potentially related to interleukin-8 receptor functionality.

Authors:  M Rambeaud; G M Pighetti
Journal:  Immunogenetics       Date:  2006-11-21       Impact factor: 2.846

6.  Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.

Authors:  W B Breunis; M H Biezeveld; J Geissler; I M Kuipers; J Lam; J Ottenkamp; A Hutchinson; R Welch; S J Chanock; T W Kuijpers
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

Review 7.  Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer.

Authors:  M Brueckmann; M Borggrefe
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

8.  Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.

Authors:  Rachel Nadif; Margaret Mintz; Selma Rivas-Fuentes; Anne Jedlicka; Elise Lavergne; Mathieu Rodero; Francine Kauffmann; Christophe Combadière; Steven R Kleeberger
Journal:  Cytokine       Date:  2006-02-07       Impact factor: 3.861

9.  Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury.

Authors:  Tejbeer Kaur; Kevin K Ohlemiller; Mark E Warchol
Journal:  J Comp Neurol       Date:  2017-12-17       Impact factor: 3.215

10.  Cloning and functional characterization of the human fractalkine receptor promoter regions.

Authors:  Alexandre Garin; Philippe Pellet; Philippe Deterre; Patrice Debré; Christophe Combadière
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.